Exploratory efficacy of INP104 in patients using concomitant preventive migraine medications

被引：0
|
作者：
Grant, J. [1 ]
Vann, R. [2 ]
Fitzpatrick, C. [2 ]
Lieu, T. [2 ]
Shrewsbury, S. B. [2 ]
Aurora, S. K. [2 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Neurol, Headache & Facial Pain Ctr, New York, NY 10029 USA
[2] Impel NeuroPharma Inc, Seattle, WA USA
来源：
HEADACHE | 2022年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-174
引用
收藏
页码：147 / 148
页数：2
相关论文
共 50 条
  • [1] Exploratory efficacy of INP104 in migraine patients by prior treatment
    Bilchik, T. R.
    Vann, R.
    Murphy, M.
    Ray, S.
    Shrewsbury, S. B.
    Aurora, S. K.
    HEADACHE, 2022, 62 : 147 - 147
  • [2] Safety and Efficacy of Concomitant Erenumab and INP104 Use From the Phase 3 STOP 301 Study in Migraine Patients
    Ahmed, Zubair
    Vann, Robert
    Fitzpatrick, Christopher
    Ray, Sutapa
    Shrewsbury, Stephen
    Aurora, Sheena
    NEUROLOGY, 2023, 100 (17)
  • [3] Safety of Concomitant Triptan and INP104 Use From the Phase 3 STOP 301 Study in Migraine Patients
    Feoktistov, A.
    Vann, R.
    Gutierrez, J.
    Ray, S.
    Shrewsbury, S.
    Aurora, S.
    HEADACHE, 2023, 63 : 166 - 166
  • [4] Safety of Concomitant Triptan and INP104 Use From the Phase 3 STOP 301 Study in Migraine Patients
    Feoktistov, Alexander
    Vann, Robert
    Gutierrez, Judie
    Ray, Sutapa
    Shrewsbury, Stephen
    Aurora, Sheena
    NEUROLOGY, 2023, 100 (17)
  • [5] Exploratory Efficacy of INP104 by Migraine Attack Severity and Time of Dosing: Results From the Phase 3 STOP 301 Study
    Loftus, Brian D.
    Murphy, Michelle
    Fitzpatrick, Christopher J.
    Ray, Sutapa
    Shrewsbury, Stephen B.
    Aurora, Sheena K.
    NEUROLOGY, 2022, 98 (18)
  • [6] Acute treatment of migraine with INP104: Exploratory efficacy from the phase 3 open-label STOP 301 study
    Smith, T. R.
    Aurora, S. K.
    Hocevar-Trnka, J.
    Shrewsbury, S. B.
    HEADACHE, 2021, 61 : 108 - 108
  • [7] Early prediction of response to INP104 for the acute treatment of migraine
    Sacco, S.
    Vann, R.
    Lieu, T.
    Ray, S.
    Shrewsbury, S. B.
    Aurora, S. K.
    HEADACHE, 2022, 62 : 127 - 128
  • [8] Real-World Assessment of Concomitant Medication Use in Patients Using INP104 in the United States
    Gill, N.
    Ahmed, Z.
    Vann, R.
    Gutierrez, J.
    Ray, S.
    Aurora, S.
    HEADACHE, 2023, 63 : 157 - 158
  • [9] INP104: a drug evaluation of a nonoral product for the acute treatment of migraine
    Starling, Amaal J.
    Mallick-Searle, Theresa
    Shrewsbury, Stephen B.
    Aurora, Sheena K.
    PAIN MANAGEMENT, 2023, 13 (05) : 283 - 298
  • [10] Assessing the comparative efficacy of INP104 for acute treatment of migraine attacks: A matching-adjusted indirect comparison
    Joshi, S.
    Aurora, S. K.
    Wang, S.
    Park, J. E.
    Wu, P.
    Keeping, S. T.
    Bariahtaris, S.
    Shrewsbury, S. B.
    HEADACHE, 2021, 61 : 56 - 56
12345